Fairmount Funds Management’s Spyre Therapeutics SYRE Stock Holding History

Fairmount Funds Management’s Portfolio SYRE Stock Details SYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$60.2M	Hold
2025 Q1	$64.8M	Hold
2024 Q4	$93.5M	Hold
2024 Q3	$118M	Hold
2024 Q2	$94.5M	Buy
2024 Q1	$14.4M	Hold
2023 Q4	$8.14M	Hold
2023 Q3	$4.64M	Sell
2023 Q2	$4.26M	Buy